Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis.

Hanns P, Paczulla AM, Medinger M, Konantz M, Lengerke C.

Cell Stress. 2019 Jun 4;3(7):221-235. doi: 10.15698/cst2019.07.192. Review.

2.

Hepatotoxicity Due to Azole Antimycotic Agents in a HLA B*35:02-Positive Patient.

Bühler T, Medinger M, Bouitbir J, Krähenbühl S, Leuppi-Taegtmeyer A.

Front Pharmacol. 2019 Jun 11;10:645. doi: 10.3389/fphar.2019.00645. eCollection 2019.

3.

Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.

Soltermann Y, Heim D, Medinger M, Baldomero H, Halter JP, Gerull S, Arranto C, Passweg JR, Kleber M.

Ann Hematol. 2019 Jun;98(6):1485-1493. doi: 10.1007/s00277-019-03673-3. Epub 2019 Mar 26.

PMID:
30915500
4.

Predictors of impaired bone health in long-term survivors after allogeneic stem cell transplantation.

Baumgartner A, Moesch M, Zumsteg M, Struja T, Bernet S, Medinger M, Mueller B, Passweg J, Bargetzi M, Schuetz P.

Bone Marrow Transplant. 2019 Feb 26. doi: 10.1038/s41409-019-0484-6. [Epub ahead of print]

PMID:
30809037
5.

Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party.

Bazarbachi A, Labopin M, Battipaglia G, Djabali A, Passweg J, Socié G, Forcade E, Blaise D, Chevallier P, Orvain C, Cornelissen JJ, Arcese W, Chantepie S, Hashaishi K, Cheikh JE, Medinger M, Esteve J, Nagler A, Mohty M.

Haematologica. 2019 Sep;104(9):e398-e401. doi: 10.3324/haematol.2018.211615. Epub 2019 Feb 21. No abstract available.

6.

Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment.

Medinger M, Drexler B, Lengerke C, Passweg J.

Front Oncol. 2018 Dec 5;8:587. doi: 10.3389/fonc.2018.00587. eCollection 2018. Review.

7.

Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

Bianchi M, Heim D, Lengerke C, Halter J, Gerull S, Kleber M, Tsakiris DA, Passweg J, Tzankov A, Medinger M.

Ann Hematol. 2019 Apr;98(4):971-977. doi: 10.1007/s00277-018-3577-1. Epub 2018 Dec 12.

PMID:
30542943
8.

Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.

Kuster S, Stampf S, Gerber B, Baettig V, Weisser M, Gerull S, Medinger M, Passweg J, Schanz U, Garzoni C, Berger C, Chalandon Y, Mueller NJ, van Delden C, Neofytos D, Khanna N; Swiss Transplant Cohort Study.

Transpl Infect Dis. 2018 Dec;20(6):e12981. doi: 10.1111/tid.12981. Epub 2018 Sep 4.

PMID:
30144374
9.

Baseline calprotectin fails to predict incidence of acute gastrointestinal graft vs. host disease: a prospective study.

Schmidlin N, Passweg JR, Halter JP, Heim D, Infanti L, Stern A, Plattner A, Plattner R, Medinger M, Kleber M, Rothen C, Buser A, Bucher C, Holbro A.

Bone Marrow Transplant. 2019 Feb;54(2):343-347. doi: 10.1038/s41409-018-0292-4. Epub 2018 Aug 14. No abstract available.

PMID:
30108329
10.

High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.

Kraft S, Bollinger N, Bodenmann B, Heim D, Bucher C, Lengerke C, Kleber M, Tsakiris DA, Passweg J, Tzankov A, Medinger M.

Bone Marrow Transplant. 2019 Apr;54(4):540-548. doi: 10.1038/s41409-018-0293-3. Epub 2018 Aug 14.

PMID:
30108323
11.

What the internist should know about stem cell transplant in the elderly patient.

Medinger M, Passweg J.

Eur J Intern Med. 2018 Dec;58:43-47. doi: 10.1016/j.ejim.2018.06.018. Epub 2018 Jun 28. Review.

PMID:
29960832
12.

Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis.

Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Medinger M, Sørensen SS, Dauber EM, Böhmig G, Regele H, Berlakovich GA, Wekerle T, Oberbauer R.

Am J Transplant. 2019 Feb;19(2):475-487. doi: 10.1111/ajt.14970. Epub 2018 Jul 13.

13.

Severe anemia after trans-catheter arterial chemoembolization-an unusual presentation of hemoglobin Zurich.

Böhme T, Medinger M, Suenderhauf C, Speer O, Schmugge M, Passweg J, Bachofner A.

Ann Hematol. 2018 Nov;97(11):2249-2251. doi: 10.1007/s00277-018-3353-2. Epub 2018 May 8. No abstract available.

PMID:
29740684
14.

Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.

Rovó A, Kulasekararaj A, Medinger M, Chevallier P, Ribera JM, Peffault de Latour R, Knol C, Iacobelli S, Kanfer E, Bruno B, Maury S, Quarello P, Koh MBC, Schouten H, Blau IW, Tichelli A, Hill A, Risitano A, Passweg J, Marsh J, Dreger P, Dufour C; Severe Aplastic Anaemia Working Party of the EBMT.

Br J Haematol. 2019 Jan;184(2):294-298. doi: 10.1111/bjh.15074. Epub 2017 Dec 19. No abstract available.

PMID:
29265360
15.

Transient focal neurologic deficits upon hematopoietic stem cell transplantation: just a coincidence?

Polymeris AA, Stehle GT, Medinger M, De Marchis GM.

Acta Neurol Belg. 2019 Mar;119(1):129-131. doi: 10.1007/s13760-017-0846-z. Epub 2017 Oct 17. No abstract available.

PMID:
29043610
16.

Acute myeloid leukaemia genomics.

Medinger M, Passweg JR.

Br J Haematol. 2017 Nov;179(4):530-542. doi: 10.1111/bjh.14823. Epub 2017 Jun 27. Review.

PMID:
28653397
17.

Beneficial role of increased FOXP3+ regulatory T-cells in acute myeloid leukaemia therapy response.

Menter T, Kuzmanic B, Bucher C, Medinger M, Halter J, Dirnhofer S, Tzankov A.

Br J Haematol. 2018 Aug;182(4):581-583. doi: 10.1111/bjh.14819. Epub 2017 Jun 27. No abstract available.

PMID:
28653378
18.

Fungemia and necrotic lymph node infection with Sporopachydermia cereana in a patient with acute myeloid leukemia.

Kingston C, Medinger M, Banderet-Uglioni F, Bassetti S, Bargetzi M, Haubitz S, Fux CA, Bättig V, Goldenberger D, Passweg J, Heizmann M.

Int J Infect Dis. 2017 Aug;61:103-106. doi: 10.1016/j.ijid.2017.06.017. Epub 2017 Jun 23. Review.

19.

Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation.

Tichelli A, Gerull S, Holbro A, Buser A, Nair G, Medinger M, Heim D, Halter JP, Passweg JR.

Bone Marrow Transplant. 2017 Oct;52(10):1436-1442. doi: 10.1038/bmt.2017.115. Epub 2017 Jun 26.

PMID:
28650451
20.

Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.

Medinger M, Zeiter D, Heim D, Halter J, Gerull S, Tichelli A, Passweg J, Nigro N.

Leuk Res. 2017 Jul;58:43-47. doi: 10.1016/j.leukres.2017.04.003. Epub 2017 Apr 13.

PMID:
28433882
21.

Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison.

Baumgartner A, Bargetzi M, Bargetzi A, Zueger N, Medinger M, Passweg J, Schanz U, Samaras P, Chalandon Y, Pichard C, Limonta A, Wannesson L, Pabst T, Duchosal MA, Hess U, Stanga Z, Mueller B, Schuetz P.

Nutrition. 2017 Mar;35:43-50. doi: 10.1016/j.nut.2016.10.007. Epub 2016 Oct 15.

PMID:
28241989
22.

Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.

Paczulla AM, Dirnhofer S, Konantz M, Medinger M, Salih HR, Rothfelder K, Tsakiris DA, Passweg JR, Lundberg P, Lengerke C.

Haematologica. 2017 May;102(5):854-864. doi: 10.3324/haematol.2016.153528. Epub 2017 Feb 9.

23.

Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.

Knüppel E, Medinger M, Stehle G, Infanti L, Halter J, Burkhalter F, Mujagic E, Heim D, Passweg J.

Ann Hematol. 2017 Apr;96(4):703-705. doi: 10.1007/s00277-017-2936-7. Epub 2017 Feb 3. No abstract available.

PMID:
28160086
24.

Revisiting nutritional support for allogeneic hematologic stem cell transplantation-a systematic review.

Baumgartner A, Bargetzi A, Zueger N, Bargetzi M, Medinger M, Bounoure L, Gomes F, Stanga Z, Mueller B, Schuetz P.

Bone Marrow Transplant. 2017 Apr;52(4):506-513. doi: 10.1038/bmt.2016.310. Epub 2017 Jan 9. Review.

PMID:
28067888
25.

Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity.

Hammann F, Gotta V, Conen K, Medinger M, Cesana P, Rochlitz C, Taegtmeyer AB.

Br J Clin Pharmacol. 2017 Apr;83(4):927-930. doi: 10.1111/bcp.13155. Epub 2016 Nov 20.

26.

Novel therapeutic options in Acute Myeloid Leukemia.

Medinger M, Lengerke C, Passweg J.

Leuk Res Rep. 2016 Oct 1;6:39-49. eCollection 2016. Review.

27.

Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML).

Fridle C, Medinger M, Wilk MC, Seipel K, Passweg J, Manz MG, Pabst T.

Leuk Lymphoma. 2017 May;58(5):1068-1075. doi: 10.1080/10428194.2016.1235274. Epub 2016 Oct 13.

PMID:
27735213
28.

Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation.

Baumgartner A, Zueger N, Bargetzi A, Medinger M, Passweg JR, Stanga Z, Mueller B, Bargetzi M, Schuetz P.

Ann Nutr Metab. 2016;69(2):89-98. Epub 2016 Sep 17.

29.

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.

Medinger M, Lengerke C, Passweg J.

Cancer Genomics Proteomics. 2016 09-10;13(5):317-29. Review.

30.

Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation.

Ecsedi M, Schmohl J, Zeiser R, Drexler B, Halter J, Medinger M, Duyster J, Kanz L, Passweg J, Finke J, Bethge W, Lengerke C.

Ann Hematol. 2016 Oct;95(10):1627-36. doi: 10.1007/s00277-016-2758-z. Epub 2016 Aug 2.

PMID:
27480090
31.

Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel Agents.

Medinger M, Halter J, Heim D, Buser A, Gerull S, Lengerke C, Passweg J.

Cancer Genomics Proteomics. 2016 Jul-Aug;13(4):275-9.

PMID:
27365377
32.

Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

Medinger M, Heim D, Gerull S, Halter J, Krenger W, Buser A, Lengerke C, Bucher C, Passweg J.

Leuk Res. 2016 Aug;47:22-5. doi: 10.1016/j.leukres.2016.05.011. Epub 2016 May 17.

PMID:
27239737
33.

Numerical impairment of nestin(+) bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML.

Medinger M, Krenger W, Jakab A, Halter J, Buser A, Bucher C, Passweg J, Tzankov A.

Bone Marrow Transplant. 2015 Nov;50(11):1453-8. doi: 10.1038/bmt.2015.189. Epub 2015 Aug 24.

PMID:
26301968
34.

Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation.

Tschan-Plessl A, Halter JP, Heim D, Medinger M, Passweg JR, Gerull S.

Ann Hematol. 2015 Nov;94(11):1899-905. doi: 10.1007/s00277-015-2461-5. Epub 2015 Aug 2.

PMID:
26233683
35.

Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation.

Binkert L, Medinger M, Halter JP, Heim D, Gerull S, Holbro A, Lengerke C, Weisser M, Passweg JR.

Bone Marrow Transplant. 2015 Oct;50(10):1331-6. doi: 10.1038/bmt.2015.148. Epub 2015 Jun 29.

PMID:
26121111
36.

High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.

Passweg JR, Schanz U, Chalandon Y, Güngör T, Baldomero H, Heim D, Nair G, Medinger M, Masouridi-Levrat S, de Faveri GN, Tiercy JM; Swiss Blood Stem Cell Transplantation Group.

Bone Marrow Transplant. 2015 Sep;50(9):1201-5. doi: 10.1038/bmt.2015.129. Epub 2015 Jun 8.

PMID:
26052916
37.

Angiogenic markers in plasma cell myeloma patients treated with novel agents.

Medinger M, Halter J, Heim D, Buser A, Gerull S, Stern M, Passweg J.

Anticancer Res. 2015 Feb;35(2):1085-90.

PMID:
25667497
38.

Angiogenesis in myeloproliferative neoplasms, new markers and future directions.

Medinger M, Passweg J.

Memo. 2014;7:206-210. Epub 2014 May 22. Review.

39.

Influence of selective serotonin reuptake inhibitors on bleeding risk in patients with severe thrombocytopenia after chemotherapy: a retrospective study.

Schäfer C, O'Meara A, Tsakiris DA, Medinger M, Passweg JR, Stern M.

Acta Haematol. 2015;133(3):317-20. doi: 10.1159/000366551. Epub 2014 Dec 2. No abstract available.

PMID:
25471100
40.

Role of tumour angiogenesis in haematological malignancies.

Medinger M, Passweg J.

Swiss Med Wkly. 2014 Nov 6;144:w14050. doi: 10.4414/smw.2014.14050. eCollection 2014. Review.

41.

Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis.

Mross K, Büchert M, Frost A, Medinger M, Stopfer P, Studeny M, Kaiser R.

BMC Cancer. 2014 Jul 11;14:510. doi: 10.1186/1471-2407-14-510.

42.

Evaluation of the pretransplantation workup before allogeneic transplantation.

Gerull S, Medinger M, Heim D, Passweg J, Stern M.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1852-6. doi: 10.1016/j.bbmt.2014.06.029. Epub 2014 Jun 27.

43.

Aplastic anemia: possible associations with lymphoproliferative neoplasms.

Tzankov A, Medinger M.

Int J Lab Hematol. 2014 Jun;36(3):382-7. doi: 10.1111/ijlh.12224. Review.

PMID:
24750685
44.

Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma.

Rueff J, Medinger M, Heim D, Passweg J, Stern M.

Biol Blood Marrow Transplant. 2014 Jun;20(6):896-9. doi: 10.1016/j.bbmt.2014.03.007. Epub 2014 Mar 13.

45.

Forty years of haematopoietic stem cell transplantation: a review of the Basel experience.

O'Meara A, Holbro A, Meyer S, Martinez M, Medinger M, Buser A, Halter J, Heim D, Gerull S, Bucher C, Rovo A, Kühne T, Tichelli A, Gratwohl A, Stern M, Passweg JR.

Swiss Med Wkly. 2014 Feb 24;144:w13928. doi: 10.4414/smw.2014.13928.

46.

Dkk3 levels in patients with myeloproliferative neoplasms.

Medinger M, Muesser P, Girsberger S, Skoda R, Tzankov A, Buser A, Passweg J, Tsakiris DΑ.

Thromb Res. 2014 Feb;133(2):218-21. doi: 10.1016/j.thromres.2013.11.003. Epub 2013 Nov 14.

PMID:
24309205
47.

Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD.

Bürgler D, Medinger M, Passweg J, Fischmann A, Bucher C.

Leuk Res. 2014 Feb;38(2):184-7. doi: 10.1016/j.leukres.2013.10.024. Epub 2013 Nov 5.

PMID:
24268317
48.

Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.

Meyer SC, Medinger M, Halter JP, Baldomero H, Hirsch HH, Tzankov A, Dirnhofer S, Passweg JR, Tichelli A.

Hematology. 2014 Jul;19(5):280-5. doi: 10.1179/1607845413Y.0000000123. Epub 2013 Nov 25.

PMID:
24074746
49.

Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs).

Pircher A, Fiegl M, Untergasser G, Heidegger I, Medinger M, Kern J, Hilbe W.

Lung Cancer. 2013 Aug;81(2):252-8. doi: 10.1016/j.lungcan.2013.04.014. Epub 2013 May 10.

PMID:
23664449
50.

[Neutropenia and fever of unknown origin].

Gavillet M, Medinger M, Tichelli A, Fux-Arnold C.

Praxis (Bern 1994). 2012 Nov 28;101(24):1573-6. doi: 10.1024/1661-8157/a001131. German.

PMID:
23184550

Supplemental Content

Loading ...
Support Center